A novel role for IL-22R1 as a driver of inflammation

scientific article

A novel role for IL-22R1 as a driver of inflammation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2010-05-285908
P932PMC publication ID3031481
P698PubMed publication ID20971950
P5875ResearchGate publication ID47534736

P50authorRaymond P. DonnellyQ40102325
Adelle P McFarlandQ56839862
Stefania PittalugaQ87358458
Wyndham H. WilsonQ110350523
Kieron DunleavyQ114521842
P2093author name stringLionel Feigenbaum
Dennis M Klinman
Ram Savan
Hidekazu Shirota
Stephen K Anderson
Howard A Young
Della A Reynolds
Karthika Ramakrishnan
Megan Karwan
P2860cites workInterleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22RQ22254431
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent mannerQ24644925
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersQ24646379
Structure of IL-22 bound to its high-affinity IL-22R1 chainQ24656543
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokinesQ24678115
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1Q24685212
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell deathQ28202067
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaQ33634415
Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexesQ33921809
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomasQ34037769
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airwaysQ34492076
Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptorsQ35848928
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cellsQ35849172
What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?Q36132014
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphomaQ36193920
The anaplastic lymphoma kinase in the pathogenesis of cancerQ37039605
IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphomaQ37278507
Extreme neutrophil granulocytosis in a patient with anaplastic large cell lymphoma of T-cell lineage.Q40448136
Genomic structure and inducible expression of the IL-22 receptor alpha chain in miceQ40666390
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.Q40721858
Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.Q42814341
A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain geneQ44270446
Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphomaQ46695204
Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilizationQ52507472
Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.Q54512003
Neutrophil-rich anaplastic large cell lymphoma (NR-ALCL) mimicking lymphadenitis: a study by fine-needle aspiration biopsyQ80549121
Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphomaQ82917953
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
P304page(s)575-584
P577publication date2010-10-22
P1433published inBloodQ885070
P1476titleA novel role for IL-22R1 as a driver of inflammation
P478volume117

Reverse relations

cites work (P2860)
Q38170180A tale of two cytokines: IL-17 and IL-22 in asthma and infection
Q47631823ALK is a therapeutic target for lethal sepsis.
Q46178702An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
Q54371901Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression.
Q49837454Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Q47390109Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth
Q90695381Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Q45996759Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children.
Q37994612Cytokine-based therapy in psoriasis
Q57174069Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma
Q35133818Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses
Q34454590Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma
Q36658484Genetics of Bladder Malignant Tumors in Childhood
Q38081171IL-22, not simply a Th17 cytokine
Q54981113Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.
Q35074604In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression
Q36531638Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis
Q38325566Innate lymphoid cells involve in tumorigenesis.
Q53542274Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
Q39314776Interleukin 17 is a chief orchestrator of immunity
Q43102028Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
Q26752528Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
Q84365414Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
Q38615132JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22 On Aortic Dissection with Acute Lung Injury.
Q34841987Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region
Q38942795Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma
Q91307598Molecular signature of interleukin-22 in colon carcinoma cells and organoid models
Q42391532Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ injuries in a rat model of hemorrhagic shock
Q39259618PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
Q38366661Pivotal roles of ILCs in hepatic diseases
Q41999154Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?
Q40193407Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry
Q52806518The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma.
Q26799454The Newly Identified T Helper 22 Cells Lodge in Leukemia
Q38184626The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome.